AMED Released to Support a Clinical Trial of GAIA-102 to Treat Pediatric Solid Tumors
*AMED just released that the ‘Program for Translational Medicine’ has accepted the grant application for a Physician-Originated Phase I Clinical Trial of GAIA-102 for pediatric solid tumors by Kyushu University team. The grant will support approximately 100M JPY per year as a 3-year project of the Seeds C category.
The Principal Investigators of the trial are Professor Tatsuro Tajiri and Dr. Naonori Kawakubo at the Department of Pediatric Surgery, Kyushu University Hospital. The Principal Researcher is Dr. Yoshi Yonemitsu, a professor at Kyushu University Graduate School of Pharmaceutical Sciences. The first patient-in of this clinical trial is estimated in August 2022.
GAIA BioMedicine Inc. will support its clinical trial by supplying GAIA-102.
*AMED: Japan Agency for Medical Research and Development
AMED Release HP: https://www.amed.go.jp/koubo/16/01/1601C_00024.html